Supplementary Table 1: miR-125a-5p expression across different databases

miR-125a-5p / ORDET / Biagioni et al / CGAN / Farazi et al / Enerly et al
Tumor* / 133(cases) / 63 / 694 / 168 / 101
Peritumor* / - / 59 / 83 / - / -
Normal* / 133(controls) / - / - / 11 / -
Platform / Agilent / Agilent / Illumina / Solexa / Agilent
Subsets / case vs control / T vs PT / T vs PT/
LumAvs HER2
LumBvs HER2 / DCIS vs normal/IDC HER2+ ER- vs normal / Basal vsLumA
mut p53 vswt p53
ER-
Modulation / Down / Up / Down/Up / Down/Up / Down

Supplementary Table 2:miR-99b expression across different databases

miR-99b / ORDET / Biagioni et al / CGAN / Farazi et al / Enerly et al
Tumor* / 133(cases) / 63 / 694 / 168 / 101
Peritumor* / - / 59 / 83 / - / -
Normal* / 133(controls) / - / - / 11 / -
Platform / Agilent / Agilent / Illumina / Solexa / Agilent
Subsets / case vs control / T vs PT / T vs PT/
LumAvs HER2;
LumA vs LumB;
LumA vs Basal / DCIS vs normal; IDC HER2+ ER- vs normal / Basal vsLumA
mut p53 vswt p53
ER- p53 mutvs
ER- p53 wt
Modulation / Down / - / Up/Down / Down / Down

Supplementary Table 3: miR-199a-5p expression across different databases

miR-199a-5p / ORDET / Biagioni et al / CGAN / Farazi et al / Enerly et al
Tumor* / 133(cases) / 63 / 694 / 168 / 101
Peritumor* / - / 59 / 83 / - / -
Normal* / 133(controls) / - / - / 11 / -
Platform / Agilent / Agilent / Illumina / Solexa / Agilent
Subsets / case vs control / T vs PT / T vs PT/
LumAvs HER2;
LumA vs LumB;
LumA vs Basal / - / Basal vsLumA;
mut p53 vswt p53;
ER- p53 mutvs ER- p53 wt
Modulation / Down / Up / Down/Up / - / Down

Supplementary Table 4: miR-199b-5p expression across different databases

miR-199b-5p / ORDET / Biagioni et al / CGAN / Farazi et al / Enerly et al
Tumor* / 133 (cases) / 63 / 694 / 168 / 101
Peritumor* / - / 59 / 83 / - / -
Normal* / 133 (controls) / - / - / 11 / -
Platform / Agilent / Agilent / Illumina / Solexa / Agilent
Subsets / case vs control / T vs PT / T vs PT/
LumAvs HER2;
LumA vs LumB;
LumA vs Basal / - / Basal vsLumA;
mut p53 vswt p53;
ER- p53 mutvs ER- p53 wt
Modulation / Down / - / Down/Up / - / Down

Supplementary Table 5: miR-892b expression across different databases

miR-892b / ORDET / Biagioni et al / CGAN / Farazi et al / Enerly et al
Tumor* / 133(cases) / 63 / 694 / 168 / 101
Peritumor* / - / 59 / 83 / - / -
Normal* / 133(controls) / - / - / 11 / -
Platform / Agilent / Agilent / Illumina / Solexa / Agilent
Subsets / case vs control / T vs PT / - / - / Basal vsLumA;
mut p53 vswt p53;
ER- p53 mutvs ER- p53 wt
Modulation / Up / Down / - / - / -

Supplementary Table 6: miR-141 expression across different databases

miR-141 / ORDET / Biagioni et al / CGAN / Farazi et al / Enerly et al
Tumor* / 133(cases) / 63 / 694 / 168 / 101
Peritumor* / - / 59 / 83 / - / -
Normal* / 133(controls) / - / - / 11 / -
Platform / Agilent / Agilent / Illumina / Solexa / Agilent
Subsets / case vs control / T vs PT / T vs PT/
LumAvs Basal;
LumAvsLumB;
HER2 vs Basal / DCIS vs normal; IDC HER2+ ER- vs normal / ER+ vs ER-
Modulation / Down / Up / Up/Down / Up / Up

Supplementary Table 7: miR-582-5p expression across different databases

miR-582-5p / ORDET / Biagioni et al / CGAN / Farazi et al / Enerly et al
Tumor* / 133 (cases) / 63 / 694 / 168 / 101
Peritumor* / - / 59 / 83 / - / -
Normal* / 133 (controls) / - / - / 11 / -
Platform / Agilent / Agilent / Illumina / Solexa / Agilent
Subsets / case vs control / T vs PT / T vs PT/
LumAvs HER2;
LumAvs Basal; LumBvs HER2;
lumBvs Basal; HER2 vs Basal / - / Basal vsLumA;
mut p53 vswt p53;
ER- p53 mutvs ER- p53 wt
Modulation / Down / Up / Up/Down / - / -

Supplementary Table 8: miR-138 expression across different databases

miR-138 / ORDET / Biagioni et al / CGAN / Farazi et al / Enerly et al
Tumor* / 133(cases) / 63 / 694 / 168 / 101
Peritumor* / - / 59 / 83 / - / -
Normal* / 133(controls) / - / - / 11 / -
Platform / Agilent / Agilent / Illumina / Solexa / Agilent
Subsets / case vs control / T vs PT / - / - / -
Modulation / Down / Down / - / - / -

Supplementary Table 9: miR-181c* expression across different databases

miR-181c* / ORDET / Biagioni et al / CGAN / Farazi et al / Enerly et al
Tumor* / 133 (cases) / 63 / 694 / 168 / 101
Peritumor* / - / 59 / 83 / - / -
Normal* / 133 (controls) / - / - / 11 / -
Platform / Agilent / Agilent / Illumina / Solexa / Agilent
Subsets / case vs control / T vs PT / T vs PT;
LumAvs HER2;
LumA vs LumB/
LumA vs Basal;
LumBvs Basal;
HER2 vs Basal / DCIS vs normal; DCIS vs IDC HER2+ ER- / mut p53 vswt p53;
ER+ p53 mutvs ER+ p53 wt
Modulation / Down / - / Up/Down / Down / Down

Supplementary Table 10: miR-28-3p expression across different databases

miR-28-3p / ORDET / Biagioni et al / CGAN / Farazi et al / Enerly et al
Tumor* / 133 (cases) / 63 / 694 / 168 / 101
Peritumor* / - / 59 / 83 / - / -
Normal* / 133 (controls) / - / - / 11 / -
Platform / Agilent / Agilent / Illumina / Solexa / Agilent
Subsets / case vs control / T vs PT / T vs PT
LumAvs Basal
LumBvs Basal
HER2 vs Basal
LumBvs HER2 / - / -
Modulation / Down / Down / Down / - / -

Supplementary Table 11: miR-1288 expression across different databases

miR-1288 / ORDET / Biagioni et al / CGAN / Farazi et al / Enerly et al
Tumor* / 133 (cases) / 63 / 694 / 168 / 101
Peritumor* / - / 59 / 83 / - / -
Normal* / 133 (controls) / - / - / 11 / -
Platform / Agilent / Agilent / Illumina / Solexa / Agilent
Subsets / case vs control / T vs PT / - / - / -
Modulation / Up / - / - / - / -

Supplementary Table 12: miR-224 expression across different databases

miR-224 / ORDET / Biagioni et al / CGAN / Farazi et al / Enerly et al
Tumor* / 133 (cases) / 63 / 694 / 168 / 101
Peritumor* / - / 59 / 83 / - / -
Normal* / 133 (controls) / - / - / 11 / -
Platform / Agilent / Agilent / Illumina / Solexa / Agilent
Subsets / case vs control / T vs PT / T vs PT
LumAvs HER2
LumAvs Basal
LumBvs Basal
LumBvs HER2
HER2 vs Basal / IDC HER2+ ER- vs normal / Basal vsLumA
mut p53 vswt p53
ER- p53 mutvs ER- p53 wt
ER- vs ER+
Modulation / Down / Down / Down / Up / Up

Supplementary Table 13: miR-520a-3p expression across different databases

miR-520a-3p / ORDET / Biagioni et al / CGAN / Farazi et al / Enerly et al
Tumor* / 133 (cases) / 63 / 694 / 168 / 101
Peritumor* / - / 59 / 83 / - / -
Normal* / 133 (controls) / - / - / 11 / -
Platform / Agilent / Agilent / Illumina / Solexa / Agilent
Subsets / case vs control / T vs PT / - / - / -
Modulation / Up / - / - / - / -

Supplementary Table 14: miR-223 expression across different databases

miR-223 / ORDET / Biagioni et al / CGAN / Farazi et al / Enerly et al
Tumor* / 133 (cases) / 63 / 694 / 168 / 101
Peritumor* / - / 59 / 83 / - / -
Normal* / 133 (controls) / - / - / 11 / -
Platform / Agilent / Agilent / Illumina / Solexa / Agilent
Subsets / case vs control / T vs PT / T vs PT;
LumA vs Basal;
LumB vs Basal;
Her2 vs Basal / IDC HER2+ ER- vs normal / Basal vsLumA
mut p53 vswt p53
Modulation / Down / Up / Down / Up / Up

Supplementary Table 15: miR-539 expression across different databases

miR-539 / ORDET / Biagioni et al / CGAN / Farazi et al / Enerly et al
Tumor* / 133 (cases) / 63 / 694 / 168 / 101
Peritumor* / - / 59 / 83 / - / -
Normal* / 133 (controls) / - / - / 11 / -
Platform / Agilent / Agilent / Illumina / Solexa / Agilent
Subsets / case vs control / T vs PT / T vs PT/
LumAvsLumB
LumAvs Basal
HER2 vs Basal/
LumAvs HER2
LumBvs HER2 / - / Basal vsLumA
Modulation / Down / - / - /Up/Down / - / Down

Supplementary Table 16: miR-542-5p expression across different databases

miR-542-5p / ORDET / Biagioni et al / CGAN / Farazi et al / Enerly et al
Tumor* / 133 (cases) / 63 / 694 / 168 / 101
Peritumor* / - / 59 / 83 / - / -
Normal* / 133 (controls) / - / - / 11 / -
Platform / Agilent / Agilent / Illumina / Solexa / Agilent
Subsets / case vs control / T vs PT / - / - / Basal vsLumA;
ER- p53 mutvs ER- p53 wt
Modulation / Up / Down / - / - / Down

Supplementary Table 17: miR-122* expression across different databases

miR-122* / ORDET / Biagioni et al / CGAN / Farazi et al / Enerly et al
Tumor* / 133 (cases) / 63 / 694 / 168 / 101
Peritumor* / - / 59 / 83 / - / -
Normal* / 133 (controls) / - / - / 11 / -
Platform / Agilent / Agilent / Illumina / Solexa / Agilent
Subsets / case vs control / T vs PT / - / - / -
Modulation / Up / - / - / - / -

Supplementary Table 18: miR-920 expression across different databases

miR-920 / ORDET / Biagioni et al / CGAN / Farazi et al / Enerly et al
Tumor* / 133 (cases) / 63 / 694 / 168 / 101
Peritumor* / - / 59 / 83 / - / -
Normal* / 133 (controls) / - / - / 11 / -
Platform / Agilent / Agilent / Illumina / Solexa / Agilent
Subsets / case vs control / T vs PT / - / - / -
Modulation / Down / - / - / - / -